Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 17, 2024

BUY
$0.64 - $0.92 $9,982 - $14,350
15,598 New
15,598 $14,000
Q1 2024

Aug 16, 2024

SELL
$0.64 - $0.92 $3,200 - $4,600
-5,000 Reduced 24.27%
15,598 $14,000
Q1 2024

May 15, 2024

SELL
$0.64 - $0.92 $3,200 - $4,600
-5,000 Reduced 24.27%
15,598 $14,000
Q4 2023

Aug 16, 2024

BUY
$0.68 - $0.97 $14,006 - $19,980
20,598 New
20,598 $16,000
Q4 2023

Feb 13, 2024

SELL
$0.68 - $0.97 $114,240 - $162,960
-168,000 Reduced 89.08%
20,598 $16,000
Q3 2023

Nov 15, 2023

SELL
$0.77 - $1.16 $195,965 - $295,220
-254,500 Reduced 57.44%
188,598 $177,000
Q2 2023

Aug 14, 2023

BUY
$1.01 - $1.42 $189,473 - $266,389
187,598 Added 73.42%
443,098 $500,000
Q1 2023

May 15, 2023

BUY
$0.75 - $1.98 $190,500 - $502,920
254,000 Added 16933.33%
255,500 $324,000
Q2 2022

Oct 27, 2022

SELL
$0.43 - $0.91 $430 - $910
-1,000 Reduced 40.0%
1,500 $1,000
Q2 2022

Aug 15, 2022

SELL
$0.43 - $0.91 $430 - $910
-1,000 Reduced 40.0%
1,500 $1,000
Q1 2022

Oct 27, 2022

BUY
$0.67 - $1.39 $670 - $1,390
1,000 Added 66.67%
2,500 $2,000
Q1 2022

May 13, 2022

BUY
$0.67 - $1.39 $555 - $1,152
829 Added 49.61%
2,500 $2,000
Q4 2021

Feb 14, 2022

SELL
$1.18 - $2.18 $6,415 - $11,852
-5,437 Reduced 76.49%
1,671 $2,000
Q3 2021

Nov 15, 2021

BUY
$1.48 - $2.35 $10,519 - $16,703
7,108 New
7,108 $16,000

About Cidara Therapeutics, Inc.


  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.